NMRA
Conditions for a green tick:
- Website has been verified
- Phone has been verified
- Location has been verified
Overview
The National Medicines Regulatory Authority (NMRA) of Sri Lanka, established in 2015, is the apex body responsible for ensuring the safety, quality, and efficacy of medicines, medical devices, and borderline products. It regulates manufacturing, importing, distribution, sale, and clinical trials to protect public health, operating under the Ministry of Health.
Founded Year
2015
Ownership Type
Government-Owned / State-Owned Enterprise
Business Model
B2C (Business to Consumer)
Time Zone
+5.30
Mission
To provide regulatory oversight and evidence-based decisions for medicines, healthcare products, and cosmetics to ensure their safety, quality, and efficacy for the benefit of the people of Sri Lanka.
Vision
To improve access to quality medicines, healthcare products, and cosmetics for the people of Sri Lanka.
Core Values
Safety & Efficacy: Ensuring medicines, medical devices, and cosmetics are safe and effective. Quality Assurance: Maintaining high standards in manufacturing, importation, and distribution. Ethical Regulation: Conducting clinical trials and regulating, monitoring, and evaluating, to maintain the highest ethical standards. Accessibility & Affordability: Improving access to essential medicines and reducing out-of-pocket expenses. Digitalization: Leveraging technology for, enhancing user experience, and automating workflows.
Company Tagline
Providing Quality Medicine Regulation in Sri Lanka". "Strengthening the Medicine Regulatory System – NMRA Goes Digital".
Head Office Country
Sri Lanka